Monday, 21 December 2009
UK Government Response to the LDN Now 13,000 Signature NHS Low Dose Naltrexone Trial Petition to Gordon Brown, UK Prime Minister, Gordon Brown
Text -
All drugs need to be thoroughly tested to make sure they are safe enough to be made available to patients. Most research of this kind is done by the pharmaceutical industry. The Government is aware that occasionally there will be few or no commercial incentives for companies to fund clinical trials.
The Department of Health’s National Institute for Health Research (NIHR) supports the research most likely to bring benefits to patients and to the NHS. High quality proposals for support into any aspect of human health are always welcome. The NIHR Health Technology Assessment programme in particular is keen to receive suggestions for research topics in areas of market failure. These can be sent through the open access form at: www.hta.ac.uk/suggest/index.shtml.
To date, no application has been received regarding low dose naltrexone. Any application would be considered on its merits.
----
Author's Note - There is reason to suspect the sbove is not factually correct and that one application has been made. More news to follow later.
Saturday, 12 December 2009
Audit Scotland Warns of Pressures on the NHS Scotland Budget - Low Dose Naltrexone (LDN) Savings Cannot Be Ignored
http://bit.ly/SPLDNcost
UK Telegraph - NICE Propose to Restrict Key IBD Treatments to One Year on Grounds of Cost
At £12,500 per patient per year for Infliximab versus £300 per year for Low Dose Naltrexone, it is the proverbial 'no-brainer' for the NHS to do whatever it takes to convince consultants and GPs that LDN is a suitable drug choice for IBD.
The government and public bodies need to cease dithering on this and take action now so that IBD sufferers need not suffer unnecessarily.
http://bit.ly/NICEIBD
Tuesday, 8 December 2009
Round-Up of LDN Now Low Dose Naltrexone Campaign at The Scottish Parliament Public Petitions Committee
http://bit.ly/SPLDNvid1
youtube version -
http://bit.ly/SPLDNvid
Interview segment from Holyrood TV Highlights programme (Click link 03/12/2009 and fast forward to 16:00 minutes) -
http://bit.ly/SPLDNint
Full transcript of the meeting -
http://bit.ly/SPLDNmin
Saturday, 5 December 2009
Minute from the LDN Now Scotland Scottish Parliament meeting on Low Dose Naltrexone (LDN) Availability on the NHS in Scotland
Some key quotes (Paraphrased)
Robin Harper, (Scottish Green Party) - Basis for clinical trial exists with current LDN evidence. Suggest GPs gather clinical data on LDN use.
Anne McLaughlin (SNP) - Committee needs to write to charities to ask if they will help fund trials.
Nigel Don (SNP) - LDN is a drug that treats the immune system drug and clinical trials are required for all conditions it can be shown to treat.
John Wilson (SNP) - Health charities should be encouraged to ensure they are spending money on researching all options for their patients, including LDN.
Frank McAveety (Labour) - The issue that the private sector will not fund trials due to no profit motive is clear and is noted.
Low Dose Naltrexone (LDN) Database - Update
Thanks to John Donnelly of LDN Now Ireland for this great resource, http://ldnnow.com
Wednesday, 2 December 2009
Low Dose Naltrexone (LDN) at The Scottish Parliament
Video is available here -
http://bit.ly/SPLDNvid1
Click the 01/12/2009 link and the LDN petition starts at around 40 minutes in.
Hopefully more to follow on the outcome of this committee's investigations into LDN and the NHS in Scotland.
Monday, 2 November 2009
Monday, 26 October 2009
Friday, 23 October 2009
Thursday, 22 October 2009
Mike Lucas on Low Dose Naltrexone
Why won’t the drug companies shell out cash for a promising drug that requires FDA approval?
Thursday, 17 September 2009
LDN Now Day is a Success Story
The day was a big success, around 3000 signatures have been collected, which when the site is updated will bring the total to around 7400 signatures.
As things stand at the moment, the petition is number 5 in the Health category and should move to 4 within the week.
In the overall list of all petitions it is number 24 and should be in the top 20 by the end of the week.
So, if you are a UK citizen and have yet to sign up, please do so now. If you have already signed up, please encourage at least 10 of your friends to sign up now and make this petition one that the UK Government cannot ignore.
The recent apology by Gordon Brown for Alan Turing's treatment shows that these petitions do count, so make your voice heard now. Save the NHS millions, if not billions, help improve millions of patents quality of life and health and let the government know that you will not let your health be dictated by the patent system and pharmaceutical companies profits.
Sign now - http://tinyurl.com/ldnnowpet
Write to your MP about Low Dose Naltrexone - http://writetothem.org
Find out more - http://lowdosenaltrexone.org
http://ldnnow.com
http://ldnresearchtrust.org
http://ldnhelp.com
http://ldndatabase.com
Wednesday, 16 September 2009
Mary Boyle Bradley LDN Radio Show
http://www.blogtalkradio.com/Mary-Boyle-Bradley
Subscribe via iTunes
The latest episode focusses on an interview with Celia Danks of LDN Now who beat Cancer and IBS with Low Dose Naltrexone.
Friday, 11 September 2009
Thursday, 10 September 2009
Monday, 7 September 2009
Monday, 10 August 2009
Friday, 31 July 2009
Petition - National Health Funding for Low Dose Naltrexone in Australia
National Health Funding for Low Dose Naltrexone in Australia
Published by Trevor George Stephens
Date: Jun 06, 2009
Category: Health
Region: Australia
Target: Cancer sufferers MS sufferers and HIV+ persons
Web site: http://www.lowdosen altrexone. org
Monday, 27 July 2009
UK LDN Now Day - Saturday 12th September 2009
Saturday, 25 July 2009
Friday, 24 July 2009
Thursday, 23 July 2009
Wednesday, 22 July 2009
Low Dose Naltrexone (LDN) on The Fourth Plinth, Trafalgar Square, London, Friday July 22nd 2009
UK Government Petition for Low Dose Naltrexone Trial Funding
Trafalgar Square, Fourth Plinth Web Site
Milford Haven woman petitions government for LDN (Low Dose Naltrexone) trials
"Jayne Crocker and her partner Andrew Barnett are both prescribed low dose naltrexone (LDN). They say the generic drug has been used to successfully treat cancer, autoimmune systems and central nervous system disorders. "
http://bit.ly/EVfQm
(MS) Sufferer joins in battle for trials of 'wonder drug' (Low Dose Naltrexone)
"The couple have created a petition to take their fight to 10 Downing Street, and have already gathered around 3,000 signatures.
Mr Barnett, who has secondary progressive MS, said: "We urge the Government to fund a trial of LDN on the NHS."
http://bit.ly/3Iy3sI
Saturday, 4 July 2009
Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study
Tuesday, 30 June 2009
Global Autoimmune Disease Therapeutics Market to Reach $50 Billion by 2015
http://www.prweb.com/releases/2009/06/prweb2528754.htm
Thursday, 25 June 2009
A Low Dose Naltrexone (LDN) Journal - Advice on Skipping/Double Dosing LDN
Sunday, 21 June 2009
US Democrats Produce Draft Plan for Universal Health Insurance
This story documents what could be the start of a long, long journey for the US towards the sort of Universal Health Care Coverage that it's citizens need and deserve.
Saturday, 20 June 2009
Immune Response Stimulating Drug Found to Reduce Prostate Tumour Size
Wednesday, 17 June 2009
New Yahoo! Group for Low Dose Naltrexone (LDN) Users who Have IBD (Inflammatory Bowel Disease)
http://health.groups.yahoo.com/group/LDNandIBD/
A New Low Dose Naltrexone (LDN) Petition for Australia
National Health Funding for Low Dose Naltrexone in Australia
Published by Trevor George Stephens
Date: Jun 06, 2009
Category: Health
Region: Australia
Target: Cancer sufferers MS sufferers and HIV+ persons
Web site: http://www.lowdosen altrexone. org/
Background (Preamble):
I was diagnosed as being HIV+ in 1987: I participated in the Ozone trial in
the Philippines in 1993 while practicing various alternative and natural
therapies and am 60 years of age in Sept. 2009 and am healthy and well.
I pursued further Ozone treatment in 1999 in Kenya with the scientist who
developed that particular method of delivery called Polyatomic Apheresis -
The late Basil Wainwright - and returned to Australia early 2000. I
discovered in that year a seeming decrease in my CD4 cells and a
concomitant decrease in my platelets so I went on medication then and
remained fairly steadily on it for some time - four years -with a couple of
intermittent breaks from it due to the development of small lumps in my
sides (abdominal area). In all of this time my cd4's have been only between
200 and 300: however, after being on LDN for some three months - from round
September 2008 - they showed the most significant increase I have seen
since the Ozone trial in 1993.....CD4' s were 350 and CD8's were 1096 with a
non detectable viral load.
I had a few weeks off around the Christmas and have now passed another
three/four month period taking 4.5 mg every night. My latest results at May
2009 are ... non detectable viral load and CD4 count of 293. The present
cost of this medication at the lower end of the scale is $100+.00 every
three months. I am receipt of a disability pension. I have an interest in
drawing official attention to this medication and having it listed on the
pharmaceutical benefits listings.
Please send this on to anyone within serious immune boosting concerns /
view the LDN site and sign the petition. Return this petition to me on the
20th January 2010 for review.
Click 'Tell' to send this petition on and you will assist in maintaining
its momentum and growth.
Petition:
We petition the Australian government to make funds available for trials
and research for LDN to achieve a licence and public availability. This
medication must be added to the pharmaceuticals benefits listings.
We petition the Australian government to make funding available, either
directly through taxes or indirectly by directing research bodies to
provide funding, to undergo trials for the generic drug, Low Dose
Naltrexone (LDN).
Primarily this is to be done for Cancer since there lies the biggest
savings of life and economy, but then also for the many other diseases,
such as MS, Crohns disease, Fibromyalgia, Rheumatoid Arthritis, HIV/Aids
and many more.
Alternatively, the drug should be made available on the basis of it's
widespread use and the widespread positive reports of the many doctors
around the world who are currently using it. The evidence about this drug
has overtaken the trials process already and as such, we ask also that this
drug be made available as front line treatment, now. The research should
then be performed to confirm the drug and resolve the many unanswered
questions surrounding it.
To sumarise, we ask for the funding to be provided and the drug to be made
freely available to those who request it. The drug has been proven safe at
high dose usage so the safety trials are done, and we know of no drugs
which become unsafe at low dose when safe at high ones. In 25 years, the
drug industry has ignored this drug due to lack of return on investment, so
we believe that only government led intervention can break this scandalous
apathy. LDN now, save our sick, save our economy.
Please fund LDN Now!
To sign the petition:
http://www.gopetiti on.com/online/ 28354.html
Crohn's Disease Put into Remission in Children with Supplemental Nutrition Alone
http://bit.ly/6IjAm
Sunday, 14 June 2009
LOw-Dose Naltrexone for Fibromyalgia & Chronic Fatigue Syndrome
"An exciting thing about LDN is that it's inexpensive and already on the market. Anecdotal evidence so far is very promising, as is the first clinical trial for FMS."
Friday, 12 June 2009
Low Dose Naltrexone : The Next Miracle Drug?
Certainly, there is much appeal in a naturally-acting immune modulator that is cheap and effective. We await the publication of further results."
Tuesday, 9 June 2009
UK Low Dose Naltrexone (LDN) NHS Trial Petition Surpasses 2,500 Signatures
Thursday, 4 June 2009
MS Patient Blog - Improvement Continuing Using Low Dose Naltrexone (LDN)
http://ms.about.com/b/2009/06/03/julies-low-dose-naltrexone-journal-month-15.htm
Monday, 1 June 2009
Sunday, 31 May 2009
Saturday, 30 May 2009
First European Low Dose Naltrexone (LDN) Conference, Glasgow, Scotland, UK, February 2009
First European Conference on LDN
Glasgow 25th April 2009
Glasgow University
Intro
Linda E..good LDN Research Trust
MS 20 yrs, LDN 5.5 yrs - apears totally symptom free today.
V limited mobility, cognitive issues in communicating, severe muscular problems.
Dec 2003 started LDN
Dramatic improvement in 3 weeks, fatgue, sight, bladder improved.
Set-up LDN R C as a charity, voluntary work, running costs paid,
22K raised towards clinical trial
Aim - Get LDN on NHS for everyone.
4200+ registered
3000 in UK
90% have MS
Crohn's ME Parkinson's, Cancer and other conditions
US and other countries welcome to register
Current condition - Getting an infection/virus brings up MS symptoms (Some people say they don't get inf/vir on LDN).
Dr Bob Lawrence - introduced LDN to UK
Dr Tom Gillholly - aiming for trial in UK
LDN Research - Dr Tom Gilhooly, Essential Health Clinic, Glasgow
Published research and science research needed for GPs/ NHS
1/50th standard dose of 30 yr old drug with good safety record
Summary of research
Crohns, Human Study - Penn State
TG 9/10 towards funding for first MS trial in UK
LDN - Patent protecton long gone - no pharma studies then.
Uni - Charity funding required
Hopefully government science funding in UK
Publication is required (Hence clinical use in clinic not used)
Institutional resistance - Charities are wary of LDN
Accredited Funding needed - only 1 MS one, not keen on LDN
3/4 mg is most research - not ideal - need to educate researchers
Short duration - 2/4 years needed for LDN, cancer for 5 - therefore more expensive, so need shorte cheaper studies with demonstrable
Cancer , MS- Ian Zagon - 28 yrs, multiple studies in animals (244 publications)
1981 - nalexone and cancer in mice
Dr Bihari's became interested, lots of work but unpublished. Work on HIV was refused puiblication
IZ - Opiate growth factor increased by LDN
Seems to naturally inhibits tumour growth in animals
Experimental Allergic Encephalomyelitis - induced in animals an treated wtih LDN
MS Society of America has funded research into this which will be published soon
Sep 2008 Montreal World Congress MS - presented this there
High dose naltrexone worsens EAE and makes humans feel worse
Important to take once per day - short duration
Human Studies
FM - Published last week.
1/4 million FM in UK alone
Stanford, 10 patient study
EHC, using LDN with FM for 6 months, much better than pervious treatment (80% improvement vs 20 with other approaches, nutrition etc)
Dosage very dependant. Study used 4.5 for all, TG - mostly 1 - 2 some people have trouble taking more than 1.
TG's proposed study 120 - largest ever.
Stanford 2010
Crohn's - most impressive result.
Prof Kill Smith, Penn State U
17 patients, 12 wk pilot - 4.5 mg (High) LDN
Close exam of bowel - 67% remission
89% response
TG - 3 patients , 2 with servere crohn's - both remission with 1mg quite quickly.
1 NHS patients with blody d and blood transfusion
remission for over a year (Stopped LDN as didn't like drugs but maintained remission)
IBS - Kariv, Tel Aviz - 47 @ 0.5mg 76% improvement Reduction in pain free days
600 patients ouble blind randmoised
0..5 mg (Called PTI 901)
2 momnths mprovement, not after 3
Seems like too low a dose, so IBS not proven really.
Seifrabei et al AJAS 2008
Haematological cancers
5 mth with 3mg
Sig imp in qualuty of life at 1 3 and 5 months follow up
MS
Gironi et al Milan 2008
Clinical exp LDN is best MS treatment
40 primary progressive MS (Worst case) - 6 months
LDN safe - only 1 patient progressed
Significante reduction in spasticity
No major adverse effects in any study
Cree et al - Uni Cal SF
80 pts 8 week RCT 4.5 mg
MSQLI - sig imp
Pain, mental health, cognition
Summary
Numerous publications
Diverse medical conditions
Seems to be useful for many conditions involving the immune system
---
Dickson Chemist
Home Delivery Pharmacy Services
J Stephen Dickson MRPharmS
0141 647 8032
Advice came from Pharamcy Prouction Unit at the Western
5 medic tyoes
Herbal - low reg
GSL - supermarket
P - pharmarcy
POM - presc only
CD - morpheine etc
MHRA regulated
MHRA license
Nalorex (Naltrexone) - Only for treatment of addictiion, 25mg - 200mg
Therefore, with this use - company is responsible for any ill effects, not Dr or Pharmacist
So LDN is
POM
Unlicensed indication an formulation
Responsibility is 50/50 Dr / Pharma
NHS will generally not pay (See later)
Legally, any pharmacy can prepare LDN ue to legislation which allows any sensible formulation asked for by Dr.
Sugar free, Vit C preservative, flavouring
Expiration - legally mandated but vague, therefore 28 days from date on bottle
Keep in fridge too - minimise bactereological contamination
Options - vial + syringe, filling tube/adaptor
Unit Dose Vial (UV) - one bottle pre dose - easier for ple with poor dexterity
3mg and 4.5mg caps
'Specials' regulations MHRA importing isssues etc.
v. expensive
people buying from US illegally, no Dr involved
labelled as 'vitamins' - illegal
MHRA audited Dickson - non GMP compliance was issue, warning issues and no longer imported from IRMAT.
No guidance anywhere though.
May 2009 - 2 suppliers of 30K caps per time, same price as US now
Invested 60K+ in services
now 100+ being invested
Donating 40p per prescription to fund research from May 2009
> 200 UK Drs will prescribe LDN (30K GPs in UK)
Time of day to take doesn't matter
Naltrexone will pass on the NFS for payment
Burt -
Alpha-lipoics accide 600mg 2/week + 4.5mg LDN per day for end stage cancer patients - remission
Pan can meta liver 2003
78 mths later alive and no tumour visible
Lupus an Arthritis
v. goo results
Dermatomyositis 20 % de in 1st year
Skin problems barely able to work, severe pain
ALAN on other drugs, pain down to 1/5th, 5th of muscle issues - 3 mths later
12 mths out - normal
200 ;upus patients - great results, test scale figures down to virtually 0 or 0 in 6 months
Alpha Lipoic acid - a prescription drug in much of EU (In Germant particularly)
No prescription required in Germany (Anecdotal - Dusseldorf, oriental man)
ALA affects metabolism, young people have plenty, older people don't.
Need B Vit complex to deal with B Vit depeltion
PM -
Saving Lives - One person at a time - Joseph Wouk
google LDN
healthyandessential.com
LDN Research Trust - most recommened web site
1 yr LDN - vast improvement. normal
Yahoo group for LDN
6000+ members
anecdotal = 'results not a part of an approved double-blind study" != "old wives tale"
patientslikeme forum
- backe bt pharma
103- mill USD needed for FDA/MHRA appoval
re-patent propsal - pragmatic solution, work within current system so drygs can be re-approved for new uses.
Sent to healthreform.gov for Obamha admin.
attempt to classify as 'Orphan drug' - Dr Gluck, Bihari and Wouk
LDNnow.co.uk - website for petition to number 10 for UK trials - 1801 sigs so far.
The Prompise of Low Dose Naltrexone Therapy : Potential Benefits...
Elaine A. Moore and Samantha Wilkinson
www.googleldn.com
Reverse SEO? lowdosenaltrexone.org low in results for varous condisions other than LDN itself.
gets same positon in google as 1/20 of hits site.
Need more links to site from many more web sites - SEO
naprotechnology for fertitility
LN helps fertitility
LDN used in Ireland since 2004
endorphine deficiency a problem with PMS and mis-carriage and fertility
Study was done on PSM with 25mg a day
in Ireland 170 drugs which are prescribed outside of licensing, so what's different about ldn?
Peer convern amongst doctors?
nb 75% of the infliximab patients failed in Penn study who got 66% remission
'Yasmin survivors forum' - google this for LDN an mood/PMS
'Up the Creek wth a Pddle' - Maey Anne Boyle Bradley
edometreiosis is 1/2 level of normal fertility on endorphions
polycystic disease too related to lowendorphon levels
persistent brown menstrual bleeding
PCOD
anxiety in ecessiss
Vit 3 deficiency a problem with fertility as is foo intolerence
LDN less effective with sterioud use
Menopause a big problem with PMS beforehand an low endorphons
Future for LDN - Tom G
Gps can prescribe off-license - consultants can't - hence concentrate on GPs
Mechanism - Reuction ion peroxynitrites - ONOOs - damage cell membranes, DNA an denzy,es
Measure nitrotyrosine - nitrated amino acid
Damage enzymes which produce energy from nutrition - hence fatigue of many auto immue dieases
Measurable via LP
Decreases as immune system becomes reduced and symptoms better
First test ever in the world - not validated yet so can't be charged as yet.
> 10 nmol/l bad
Pre SPMS 8 years = 183 nmol/l
1mg 130
2mg 108
3mg 5
MS
CFS/ME?FM
Psoriasis
CD
alopecia
Endometriosis
Ultricaria
Cycluc neutropenia
SLE
Cancer
Parkinson's
JIV
ALS
etc
etc
Dr Ian Zagon coming 2010 conf
Pharmacist - Skip
Vitamin D and Omega 3 are key - don't be defieicnt
zinc too